PFE Today - Aug 12: Lagging Stock Performance

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

PFE Today - Aug 12: Lagging Stock Performance

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for ya. Today, we’re talking about Pfizer, or PFE, and it had a rough go, closing the day in the red, down about 1.3%. Ouch.

So, what went down? Well, PFE got smoked today. There’s been a lot of chatter about their stock lagging behind the competition, and it’s pretty clear that investors weren’t feeling it. People hit the sell button fast, and the stock didn’t really bounce back. It’s like everyone’s just waiting for something good to happen, but today was not that day.

Now, why did this happen? One big reason floating around is that Pfizer just raised its earnings guidance for 2026, but hold up — it’s heavily relying on a drug that’s about to run out of its patent. That’s like putting all your eggs in a basket that’s got a hole in it. And there’s also this talk about them shelling out a whopping $49 billion in payouts, which is making folks a bit nervous. Add to that the fact that when you stack Pfizer against competitors, it’s been underperforming. Just not a great look.

Oh, and one more thing on the horizon — Erste Group Bank just bumped up their earnings estimates for Pfizer. So, there’s a glimmer of hope, but it’s kinda overshadowed by all the other stuff going on.

So yeah, today was a bit of a bummer for PFE. Just remember, I’m here to keep you in the loop, not to give you stock tips. Catch you later!

まだレビューはありません